Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
25.00
+9.00 (56.25%)
At close: Jul 31, 2026, 4:00 PM EDT
22.52
-2.48 (-9.92%)
After-hours: Jul 31, 2026, 7:57 PM EDT

Apnimed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-31.83-128.19-111.31-80.25-26.21
Depreciation & Amortization
0.030.030.020-
Loss (Gain) on Equity Investments
---37.5-
Stock-Based Compensation
4.043.913.031.560.99
Other Operating Activities
3.775.88-4.43-40.19
Change in Accounts Receivable
0.090.16-1.12--
Change in Accounts Payable
-4.28-1.8-0.523.161.24
Change in Unearned Revenue
-100.38-19.54-4.64--1
Change in Other Net Operating Assets
-11.46-8.416.0467.43-1.34
Operating Cash Flow
-69.19-77.83-110.2125.41-26.13
Operating Cash Flow Growth
-----
Capital Expenditures
---0.07-0.05-
Investment in Securities
--152.03-143.31-
Investing Cash Flow
--151.96-143.35-
Long-Term Debt Issued
-35---
Net Debt Issued (Repaid)
3535---
Issuance of Common Stock
0.130.120.0510.69-
Other Financing Activities
-0.45-0.24--0.03-0.5
Financing Cash Flow
76.1851.370.0510.66141.75
Foreign Exchange Rate Adjustments
----0
Net Cash Flow
6.99-26.4641.8-107.28115.62
Free Cash Flow
-69.19-77.83-110.2825.37-26.13
Free Cash Flow Growth
-----
Free Cash Flow Margin
-57.59%-202.33%-1376.42%--2612.90%
Free Cash Flow Per Share
-12.79-14.42-20.548.80-11.00
Levered Free Cash Flow
-40.52-48.85-12.35-
Unlevered Free Cash Flow
-40.52-48.85-12.35-
Change in Working Capital
-116.03-29.59-0.2470.59-1.1
SEC Filings: 10-K · 10-Q